• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PTRF/cavin-1 对于癌细胞的多药耐药性是必需的。

PTRF/cavin-1 is essential for multidrug resistance in cancer cells.

机构信息

Division of Life Sciences, College of Life Sciences and Biotechnology, Research Institute for Natural Sciences, Korea University, Seoul, 136-701, South Korea, and.

出版信息

J Proteome Res. 2013 Feb 1;12(2):605-14. doi: 10.1021/pr300651m. Epub 2013 Jan 4.

DOI:10.1021/pr300651m
PMID:23214712
Abstract

Since detergent-resistant lipid rafts play important roles in multidrug resistance (MDR), their comprehensive proteomics could provide new insights to understand the underlying molecular mechanism of MDR in cancer cells. In the present work, lipid rafts were isolated from MCF-7 and adriamycin-resistant MCF-7/ADR cells and their proteomes were analyzed by label-free quantitative proteomics. Polymerase I and transcript release factor (PTRF)/cavin-1 was measured to be upregulated along with multidrug-resistant P-glycoprotein, caveolin-1, and serum deprivation protein response/cavin-2 in the lipid rafts of MCF-7/ADR cells. PTRF knockdown led to reduction in the amount of lipid rafts on the surface of MCF7/ADR cells as determined by cellular staining with lipid raft-specific dyes such as S-laurdan2 and FITC-conjugated cholera toxin B. PTRF knockdown also reduced MDR in MCF-7/ADR cells. These data indicate that PTRF is necessary for MDR in cancer cells via the fortification of lipid rafts.

摘要

由于去污剂抗性脂质筏在多药耐药性 (MDR) 中发挥着重要作用,因此对其进行全面的蛋白质组学研究可以为理解癌细胞中 MDR 的潜在分子机制提供新的见解。在本研究中,从 MCF-7 和阿霉素耐药 MCF-7/ADR 细胞中分离出脂质筏,并通过无标记定量蛋白质组学对其蛋白质组进行分析。结果表明,随着多药耐药性 P-糖蛋白、质膜窖蛋白-1(caveolin-1)和血清剥夺蛋白反应/窖蛋白-2在 MCF-7/ADR 细胞的脂质筏中上调,聚合酶 I 和转录释放因子 (PTRF)/窖蛋白-1 (cavin-1) 的含量也随之增加。通过用脂质筏特异性染料(如 S-软脂酰-2-二氢荧光素和 FITC 缀合霍乱毒素 B)对 MCF7/ADR 细胞进行细胞染色,发现 PTRF 敲低导致 MCF-7/ADR 细胞表面脂质筏的数量减少。PTRF 敲低也降低了 MCF-7/ADR 细胞的多药耐药性。这些数据表明,PTRF 通过强化脂质筏在癌细胞的多药耐药性中是必需的。

相似文献

1
PTRF/cavin-1 is essential for multidrug resistance in cancer cells.PTRF/cavin-1 对于癌细胞的多药耐药性是必需的。
J Proteome Res. 2013 Feb 1;12(2):605-14. doi: 10.1021/pr300651m. Epub 2013 Jan 4.
2
Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.Survivin 转录与 MCF-7 乳腺癌细胞多药耐药中的 P-糖蛋白/MDR1 过表达相关。
Oncol Rep. 2010 May;23(5):1469-75. doi: 10.3892/or_00000786.
3
[Effect of different heating methods combined with neferine on the expressions of γH2AX and mdr-1/P-gp in MCF-7/Adr breast cancer cells].[不同加热方法联合甲基莲心碱对MCF-7/Adr乳腺癌细胞中γH2AX和mdr-1/P-gp表达的影响]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Apr;36(4):317-22. doi: 10.3969/j.issn.1672-7347.2011.04.007.
4
Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.柴胡皂苷D可诱导乳腺癌MCF-7/阿霉素细胞中P-糖蛋白介导的多药耐药性的逆转。
Pathol Res Pract. 2017 Jul;213(7):848-853. doi: 10.1016/j.prp.2017.01.022. Epub 2017 Feb 3.
5
Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.达沙替尼通过抑制ERK信号通路的激活来下调P-糖蛋白的表达,从而逆转乳腺癌MCF-7细胞对多柔比星的多药耐药性。
Cancer Biol Ther. 2015;16(1):106-14. doi: 10.4161/15384047.2014.987062.
6
Down-regulation of the cavin family proteins in breast cancer.乳腺癌中腔蛋白家族的下调。
J Cell Biochem. 2012 Jan;113(1):322-8. doi: 10.1002/jcb.23358.
7
Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.补骨脂素逆转人乳腺癌MCF-7/ADR细胞中P-糖蛋白介导的多药耐药性。
Mol Med Rep. 2016 Jun;13(6):4745-50. doi: 10.3892/mmr.2016.5098. Epub 2016 Apr 8.
8
Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition.Rp1 通过抑制 MDR-1 和Src 来调节脂筏,从而逆转多药耐药。
Biochem Pharmacol. 2013 May 15;85(10):1441-53. doi: 10.1016/j.bcp.2013.02.025. Epub 2013 Mar 6.
9
Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.乳腺癌细胞的长期药物选择和癌症干细胞特征的富集。
J Natl Cancer Inst. 2010 Nov 3;102(21):1637-52. doi: 10.1093/jnci/djq361. Epub 2010 Oct 8.
10
Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers.在多药耐药的胃癌和乳腺癌中,Cbl-b通过阻止P-糖蛋白转运体易位至小窝来抑制其功能。
Oncotarget. 2015 Mar 30;6(9):6737-48. doi: 10.18632/oncotarget.3253.

引用本文的文献

1
Proteomics of colorectal tumors identifies the role of CAVIN1 in tumor relapse.结直肠癌肿瘤蛋白质组学揭示了CAVIN1在肿瘤复发中的作用。
Mol Syst Biol. 2025 Apr 23. doi: 10.1038/s44320-025-00102-8.
2
Diet therapy abates mutant APC and KRas effects by reshaping plasma membrane cholesterol nanodomains.饮食疗法通过重塑质膜胆固醇纳米结构域减轻突变型APC和KRas的影响。
Biophys J. 2025 Feb 4;124(3):508-527. doi: 10.1016/j.bpj.2024.12.020. Epub 2024 Dec 20.
3
Decoding Chemotherapy Resistance of Undifferentiated Pleomorphic Sarcoma at the Single Cell Resolution: A Case Report.
单细胞分辨率下解析未分化多形性肉瘤的化疗耐药性:一例报告
J Clin Med. 2024 Nov 26;13(23):7176. doi: 10.3390/jcm13237176.
4
Cholesterol-Depletion-Induced Membrane Repair Carries a Raft Conformer of P-Glycoprotein to the Cell Surface, Indicating Enhanced Cholesterol Trafficking in MDR Cells, Which Makes Them Resistant to Cholesterol Modifications.胆固醇耗竭诱导的膜修复将 P-糖蛋白的筏状构象带到细胞表面,表明多药耐药细胞中胆固醇转运增强,使它们对胆固醇修饰具有抗性。
Int J Mol Sci. 2023 Aug 2;24(15):12335. doi: 10.3390/ijms241512335.
5
Cross-Linking Mass Spectrometry on P-Glycoprotein.P-糖蛋白的交联质谱分析。
Int J Mol Sci. 2023 Jun 25;24(13):10627. doi: 10.3390/ijms241310627.
6
PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma.PTRF/Cavin-1 通过细胞外囊泡增强胶质母细胞瘤的化疗耐药性并促进替莫唑胺外排。
Theranostics. 2022 May 16;12(9):4330-4347. doi: 10.7150/thno.71763. eCollection 2022.
7
Caveolae-Associated Molecules, Tumor Stroma, and Cancer Drug Resistance: Current Findings and Future Perspectives.小窝相关分子、肿瘤基质与癌症耐药性:当前研究结果与未来展望
Cancers (Basel). 2022 Jan 25;14(3):589. doi: 10.3390/cancers14030589.
8
Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats.抑制 PTRF 通过下调大鼠 TLR4 信号通路减轻感染后肠易激综合征
Front Pharmacol. 2021 Oct 7;12:724410. doi: 10.3389/fphar.2021.724410. eCollection 2021.
9
Integrated Bioinformatic Analysis of the Expression and Prognosis of Caveolae-Related Genes in Human Breast Cancer.人乳腺癌中小窝相关基因表达与预后的综合生物信息学分析
Front Oncol. 2021 Aug 26;11:703501. doi: 10.3389/fonc.2021.703501. eCollection 2021.
10
miR-1301-3p promotes the proliferation and migration of lung cancer cells via direct repression of polymerase I and transcript release factor.微小RNA-1301-3p通过直接抑制聚合酶I和转录释放因子促进肺癌细胞的增殖和迁移。
Oncol Lett. 2020 Dec;20(6):286. doi: 10.3892/ol.2020.12149. Epub 2020 Sep 23.